| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |